September 24, 2017 2:09 AM ET


Company Overview of GeneXP Biosciences Inc.

Key Executives for GeneXP Biosciences Inc.

NameBoard RelationshipsTitleAge
Michael Leslie Cohen BA12 RelationshipsPresident and Director44
Paul Davis Esq.12 RelationshipsCo-Founder and Executive Chairman--
Michael Simches CPANo RelationshipsChief Financial Officer--
Karen Rose No RelationshipsDirector of Operations--
David Englert Ph.D. No RelationshipsPrincipal Scientist--

GeneXP Biosciences Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Paul Davis Esq. 12 RelationshipsIntelligent Integration Systems, Inc.--
Michael Leslie Cohen BA 12 RelationshipsGeneXP Biosciences Inc.44
Steven R. Gullans Ph.D. 76 RelationshipsGemphire Therapeutics Inc.64
Richard Svrluga 21 RelationshipsExogenesis Corporation--
Raymond Stoll Ph.D. 12 RelationshipsMarinus Pharmaceuticals, Inc.--
View All Board Members

GeneXP Biosciences Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D.Steven R. Gullans76 Relationships7 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
GeneXP Biosciences Inc. CEO Compensation
Industry Average


Kannalife Sciences, Inc. Announces Nick Lowery as New Spokesperson
September 23, 2017 1:50 AM ET
Eleven Biotherapeutics, Inc. Announces Resignation of Arthur Decillis as Chief Medical Officer, Effective as of October 3, 2017
September 22, 2017 8:55 PM ET
Neuralstem, Inc. Announces Board Appointments
September 22, 2017 8:30 PM ET
NantKwest, Inc. Announces Directorate Changes
September 22, 2017 8:06 PM ET
Histogenics Corporation Announces Resignation of Gloria Matthews from Chief Medical Officer, Effective from September 29, 2017
September 22, 2017 1:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GeneXP Biosciences Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at